Drug Type Recombinant protein |
Synonyms Albrec, Medway, Recombinant human serum albumin + [5] |
Target |
Mechanism albumin agonists(Serum albumin agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date JP (19 Oct 2007), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypoalbuminemia | JP | 19 Oct 2007 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemophilia | NDA/BLA | JP | 01 Oct 2007 | |
Dry Eye Syndromes | Phase 2 | US | 01 Apr 2013 |